Stock screener

ARVN

Conviction 36HealthcareScan · Mon, Aug 10, 2026
ARVN$9.00+2.80%
ResistanceSupportVol 14Insider sell
63 bars
5
Vol MA14 1.11M
May 11May 28Jun 16Jul 6Jul 23Aug 10
ARVINAS, INC.PHARMACEUTICAL PREPARATIONSwww.arvinas.com ↗
Price9.00
Change+2.80%
Gap-0.69%
Rel volume1.89×
Avg volume949.93K
Avg $ vol8.07M
SMA 208.31
SMA 508.09
SMA 20010.61
Price vs 50+11.19%
Price vs 200-15.25%
MA stackmixed
50/200 cross—
Supertrendup · 7.68
RSI (14)62
MACD hist0.09
MACD crossbull · 4d
Stoch %K / %D63 / 52
ADX (14)20
+DI / −DI32 / 12
RSI divergence—
MACD divergence—
ATR %+4.74%
ADR %4.28%
52w high13.83
52w low6.29
From 52w high-34.96%
Above 52w low+43.00%
New 52w highNo
SqueezeFired
Bollinger width14.56%
%B1.07
Donchian pos62.68%
Donchian high9.65
Donchian low7.90
AVWAP (52w high)9.44
vs AVWAP high-4.74%
AVWAP (52w low)9.94
vs AVWAP low-9.51%
OBV trendUp
Chaikin MF (20)0.14
Today vs 20d1.89×
Avg vol (14d)1.11M
Avg vol (20d)949.93K
Avg $ vol (20d)8.07M
Market cap588.15M
RS 3m (vs SPY)-19.83%
RS 6m (vs SPY)-46.60%
RS line new highNo
Trend template2/8
Technical rank42.0
1 week+11.60%
1 month+8.77%
3 months-11.03%
6 months-33.27%
1 year+44.15%
YTD-21.58%
P/E-7.28
P/B1.05
P/S12.59
P/FCF-2.13
EPS-1.14
Div yield—
ROE-14.37%
ROA-11.97%
Debt/Eq0.00
Current7.91
EV/EBITDA-4.28
Gross margin—
Net margin-173.02%
Rev growth114.22%
EPS growth59.38%
Price target13.97
Target upside55.31%
Analyst ratingBuy
Institutional93.80%
Ent. value494.35M
Revenue249.7M
Net income169.4M
Gross profit—
Free cash flow-275.7M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out64.52M
Employees246
ListedThu, Sep 27, 2018
Free float51.98M
Float %80.6%
Short interest3.98M
Days to cover6.6d
Short volume48.6%
Squeeze score59 / 100
Next earnings—
EPS forecast—
Last EPS vs est$2.58 vs −$0.24
Last surprise+1175.0% beat
Setup gradeD
Conviction36 / 100
Pattern quality—
Tech rank42.0 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance9.28
Support7.87
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 47 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Jul 30
    1 scan
  2. Breaking out now
    Aug 4
    1 scan

Congress activity

Disclosed STOCK Act trades in ARVN

All disclosures →
No recent disclosed trades by Congress in ARVN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ARVN · 10 buys

InsiderSideShares
Bain Linda
Director · Stock Option (right to buy) · 2026-06-24
Grant22.71K
Norwalk Leslie V
Director · Common Stock · 2026-06-24
Grant15.53K
Bain Linda
Director · Common Stock · 2026-06-24
Grant15.53K
Cunningham Everett
Director · Common Stock · 2026-06-24
Grant15.53K
Cunningham Everett
Director · Stock Option (right to buy) · 2026-06-24
Grant22.71K
Kennedy Edward Moore Jr.
Director · Common Stock · 2026-06-24
Grant15.53K
Kennedy Edward Moore Jr.
Director · Stock Option (right to buy) · 2026-06-24
Grant22.71K
Morrison Briggs
Director · Common Stock · 2026-06-24
Grant15.53K
Morrison Briggs
Director · Stock Option (right to buy) · 2026-06-24
Grant22.71K
Norwalk Leslie V
Director · Stock Option (right to buy) · 2026-06-24
Grant22.71K

SEC filings

EDGAR filings in ARVN · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.